26 publications
Name | Date | Type | Actions |
---|---|---|---|
Vetoquinol and Klox Technologies Announce Global Animal Health Collaboration Agreement December 12, 2019 (Lure, France) - Vetoquinol S.A. and Klox Technologies Limited, a subsidiary of Klox Technologies Inc., have entered into an exclusive global licensing agreement, excluding the People’s Republic of China. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - October 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Q3 2019 sales: €100.2 million (Up 11.0%) The Vetoquinol Group posted sales of €100.2 million for the third quarter of 2019, up 11.0% as reported and up 9.4% at constant exchange rates compared to the same period last year. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
Voting rights | ||
First half 2019 results At its meeting on July 24, 2019, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited first half 2019 financial statements. |
Public releases | ||
Vetoquinol announces a new milestone in its industrial strategy Vetoquinol, a leading global animal health player, today announces a plan to reorganize its production facilities in Europe. This decision is in line with the Group’s strategy of streamlining operations in order to improve its response to customer needs, whether vets, breeders or pet owners. |
Public releases | ||
Programme de rachat - June 2019 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
Share Information |